25-hydroxyvitamin D and risk of myocardial infarction in men - A prospective study

被引:871
|
作者
Giovannucci, Edward [1 ,2 ,3 ,4 ]
Liu, Yan [1 ,2 ]
Hollis, Bruce W. [5 ]
Rimm, Eric B. [1 ,2 ,3 ,4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Med Univ S Carolina, Dept Pediat, Charleston, SC USA
关键词
D O I
10.1001/archinte.168.11.1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Vitamin D deficiency may be involved in the development of atherosclerosis and coronary heart disease in humans. Methods: We assessed prospectively whether plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with risk of coronary heart disease. A nested case-control study was conducted in 18 225 men in the Health Professionals Follow-up Study; the men were aged 40 to 75 years and were free of diagnosed cardiovascular disease at blood collection. The blood samples were returned between April 1, 1993, and November 30, 1999; 99% were received between April 1, 1993, and November 30, 1995. During 10 years of follow-up, 454 men developed nonfatal myocardial infarction or fatal coronary heart disease. Using risk set sampling, controls (n=900) were selected in a 2: 1 ratio and matched for age, date of blood collection, and smoking status. Results: After adjustment for matched variables, men deficient in 25(OH)D (<= 15 ng/mL [to convert to nano-moles per liter, multiply by 2.496]) were at increased risk for MI compared with those considered to be sufficient in 25(OH)D ( >= 30 ng/mL) (relative risk [RR], 2.42; 95% confidence interval [CI], 1.53-3.84; P <.001 for trend). After additional adjustment for family history of myocardial infarction, body mass index, alcohol consumption, physical activity, history of diabetes mellitus and hypertension, ethnicity, region, marine omega-3 intake, low- and high-density lipoprotein cholesterol levels, and triglyceride levels, this relationship remained significant (RR, 2.09; 95% CI, 1.24-3.54 P=.02 for trend). Even men with intermediate 25(OH)D levels were at elevated risk relative to those with sufficient 25(OH)D levels (22.6-29.9 ng/mL: RR, 1.60 [95% CI, 1.10-2.32]; and 15.0-22.5 ng/mL: RR, 1.43 [95% CI, 0.96-2.13], respectively). Conclusion: Low levels of 25 (OH) D are associated with higher risk of myocardial infarction in a graded manner, even after controlling for factors known to be associated with coronary artery disease.
引用
下载
收藏
页码:1174 / 1180
页数:7
相关论文
共 50 条
  • [1] The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality
    Acharya, Prakash
    Dalia, Tarun
    Ranka, Sagar
    Sethi, Prince
    Oni, Olurinde A.
    Safarova, Maya S.
    Parashara, Deepak
    Gupta, Kamal
    Barua, Rajat S.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (10)
  • [2] Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study
    Bertone-Johnson, Elizabeth R.
    Hankinson, Susan E.
    Forger, Nancy G.
    Powers, Sally I.
    Willett, Walter C.
    Johnson, Susan R.
    Manson, JoAnn E.
    BMC WOMENS HEALTH, 2014, 14
  • [3] SERUM 25-HYDROXYVITAMIN D AT PREGNANCY AND RISK OF BREAST CANCER IN A PROSPECTIVE STUDY
    Agborsangaya, C. B.
    Surcel, H. M.
    Toriola, A. T.
    Pukkala, E.
    Parkkila, S.
    Tuohimaa, P.
    Annekatrin, L.
    Lehtinen, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S55 - S55
  • [4] A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk
    Deschasaux, Melanie
    Souberbielle, Jean-Claude
    Latino-Martel, Paule
    Sutton, Angela
    Charnaux, Nathalie
    Druesne-Pecollo, Nathalie
    Galan, Pilar
    Hercberg, Serge
    Le Clerc, Sigrid
    Kesse-Guyot, Emmanuelle
    Ezzedine, Khaled
    Touvier, Mathilde
    BRITISH JOURNAL OF NUTRITION, 2016, 115 (02) : 305 - 314
  • [5] Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study
    Agborsangaya, Calypse B.
    Surcel, Helja-Marja
    Toriola, Adetunji T.
    Pukkala, Eero
    Parkkila, Seppo
    Tuohimaa, Pentti
    Lukanova, Annekatrin
    Lehtinen, Matti
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (03) : 467 - 470
  • [6] Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study
    Elizabeth R Bertone-Johnson
    Susan E Hankinson
    Nancy G Forger
    Sally I Powers
    Walter C Willett
    Susan R Johnson
    JoAnn E Manson
    BMC Women's Health, 14
  • [7] GENETICALLY REDUCED 25-HYDROXYVITAMIN D AND RISK OF ISCHEMIC HEART DISEASE AND MYOCARDIAL INFARCTION: A MENDELIAN RANDOMIZATION STUDY
    Jacobsen, P.
    Benn, M.
    Afzal, S.
    Nordestgaard, B.
    ATHEROSCLEROSIS, 2014, 235 (02) : E66 - E66
  • [8] 25-Hydroxyvitamin D Levels and the Risk of Stroke A Prospective Study and Meta-analysis
    Sun, Qi
    Pan, An
    Hu, Frank B.
    Manson, Joann E.
    Rexrode, Kathryn M.
    STROKE, 2012, 43 (06) : 1470 - +
  • [9] Serum 25-Hydroxyvitamin D Deficiency Increases Risk of Myocardial Infarction: Results From the Prospective Monica/Kora Augsburg Case-Cohort Study
    Karakas, Mahir
    Thorand, Barbara
    Zierer, Astrid
    Huth, Cornelia
    Meisinger, Christa
    Roden, Michael
    Rottbauer, Wolfgang
    Peters, Annette
    Koenig, Wolfgang
    Herder, Christian
    CIRCULATION, 2011, 124 (21)
  • [10] A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers
    Lim, Unhee
    Freedman, D. Michal
    Hollis, Bruce W.
    Hors, Ronald L.
    Purdue, Mark P.
    Chatterjee, Nilanjan
    Weinstein, Stephanie J.
    Morton, Lindsay M.
    Schatzkin, Arthur
    Virtamo, Jarmo
    Linet, Martha S.
    Hartge, Patricia
    Alhanes, Demetrius
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 979 - 986